OTTAWA—A group representing the country’s doctors says designing marijuana packaging should be left to federal officials and public health experts, not cannabis producers and distributors.

The Canadian Medical Association said Monday that product labelling is an important way to educate consumers, especially young people, about the risks of using marijuana.

The association is also urging Ottawa to apply the same standards to marijuana as it does to prescription medication and prohibit health claims that are not backed by research.

Read more:

Greenhouse growers take chance on cannabis in push for green

Marijuana to be sold at 9 Nova Scotia Liquor Corporation stores across the province

Liberal government grant for pot research should’ve come earlier, researchers say

“Ensuring that health products are safe and effective must be a key component of any regulations on cannabis,” said the group’s president, Dr. Laurent Marcoux.

“This is why we believe rigorous scientific evidence is needed to support claims of health benefits and to identify potential risks and adverse reactions.”

Health Canada applies different levels of scrutiny to prescription drugs than it does to non-prescription medication, natural health products, cosmetics and medical devices — a fact the medical association says is not widely understood.

The association is a voluntary group that represents most of the country’s physicians.

Consumers need to be protected from misleading health claims and says it wants a single set of regulations in place for both the medical and recreational marijuana industry, it said.

The federal government is expected to legalize recreational marijuana this summer.